Viking Therapeutics (VKTX) Q4 2022 Earnings

8FebConfirmed
Apr 22
Jul 22
Q3 2022
Q4 2022
-0.26
-0.24
-0.21
-0.19

Details

Expected EPS
-0.23
Actual EPS
-0.26
Surprise EPS
-0.03
Surprise Percent
+13.04%

Description

Viking Therapeutics (VKTX) has reported earnings of -0.26 per share for Q4 2022.

0 Comments

Share your thoughts